Annual ROE
-260.60%
-145.75%-126.90%
December 31, 2023
Summary
- As of March 10, 2025, ABEO annual return on equity is -260.60%, with the most recent change of -145.75% (-126.90%) on December 31, 2023.
- During the last 3 years, ABEO annual ROE has fallen by -200.64% (-334.62%).
- ABEO annual ROE is now -192.74% below its all-time high of 280.99%, reached on December 31, 2008.
Performance
ABEO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-227.38%
-19.53%-9.40%
September 30, 2024
Summary
- As of March 10, 2025, ABEO quarterly return on equity is -227.38%, with the most recent change of -19.53% (-9.40%) on September 30, 2024.
- Over the past year, ABEO quarterly ROE has stayed the same.
- ABEO quarterly ROE is now -122.12% below its all-time high of 1027.71%, reached on September 30, 2008.
Performance
ABEO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ABEO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -126.9% | 0.0% |
| 3 y3 years | -334.6% | -300.2% |
| 5 y5 years | -599.2% | -255.9% |
ABEO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -126.9% | at low | -115.8% | +72.3% |
| 5 y | 5-year | -433.8% | at low | -393.8% | +72.3% |
| alltime | all time | -192.7% | +91.8% | -122.1% | +78.7% |
Abeona Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -227.38%(+9.4%) |
| Jun 2024 | - | -207.85%(-74.7%) |
| Mar 2024 | - | -821.46%(+146.1%) |
| Dec 2023 | -260.60%(+126.9%) | -333.73%(+43.4%) |
| Sep 2023 | - | -232.65%(+6.9%) |
| Jun 2023 | - | -217.59%(+82.9%) |
| Mar 2023 | - | -118.99%(-18.4%) |
| Dec 2022 | -114.85%(-2.0%) | -145.87%(-30.4%) |
| Sep 2022 | - | -209.62%(+35.3%) |
| Jun 2022 | - | -154.95%(+13.1%) |
| Mar 2022 | - | -137.00%(+30.1%) |
| Dec 2021 | -117.22%(+95.5%) | -105.34%(+85.4%) |
| Sep 2021 | - | -56.82%(+8.3%) |
| Jun 2021 | - | -52.47%(+13.9%) |
| Mar 2021 | - | -46.05%(-29.0%) |
| Dec 2020 | -59.96%(+22.8%) | -64.84%(-1.7%) |
| Sep 2020 | - | -65.97%(-11.8%) |
| Jun 2020 | - | -74.77%(-10.8%) |
| Mar 2020 | - | -83.80%(+39.2%) |
| Dec 2019 | -48.82%(+31.0%) | -60.21%(-5.7%) |
| Sep 2019 | - | -63.88%(+12.1%) |
| Jun 2019 | - | -56.98%(+29.0%) |
| Mar 2019 | - | -44.18%(+22.3%) |
| Dec 2018 | -37.27%(+83.6%) | -36.12%(+12.2%) |
| Sep 2018 | - | -32.18%(+19.5%) |
| Jun 2018 | - | -26.92%(+1.4%) |
| Mar 2018 | - | -26.55%(+5.7%) |
| Dec 2017 | -20.30%(-22.6%) | -25.12%(-15.1%) |
| Sep 2017 | - | -29.58%(+4.5%) |
| Jun 2017 | - | -28.31%(+1.1%) |
| Mar 2017 | - | -27.99%(-8.5%) |
| Dec 2016 | -26.22%(-34.5%) | -30.60%(+17.8%) |
| Sep 2016 | - | -25.97%(-17.6%) |
| Jun 2016 | - | -31.51%(-6.0%) |
| Mar 2016 | - | -33.52%(-3.7%) |
| Dec 2015 | -40.05%(-92.8%) | -34.80%(-68.1%) |
| Sep 2015 | - | -109.04%(-89.8%) |
| Jun 2015 | - | -1064.96%(-584.3%) |
| Mar 2015 | - | 219.91%(+42.6%) |
| Dec 2014 | -556.02%(+1747.2%) | 154.26%(+115.8%) |
| Sep 2014 | - | 71.48%(-12.1%) |
| Jun 2014 | - | 81.28%(+2209.1%) |
| Mar 2014 | - | 3.52%(-110.7%) |
| Dec 2013 | -30.10%(-148.8%) | -33.02%(-81.7%) |
| Sep 2013 | - | -180.44%(+278.7%) |
| Jun 2013 | - | -47.65%(-925.8%) |
| Mar 2013 | - | 5.77%(-84.3%) |
| Dec 2012 | 61.68%(+328.9%) | 36.76%(-64.8%) |
| Sep 2012 | - | 104.50%(+62.3%) |
| Jun 2012 | - | 64.40%(+148.2%) |
| Mar 2012 | - | 25.95%(+124.7%) |
| Dec 2011 | 14.38% | 11.55%(+415.6%) |
| Sep 2011 | - | 2.24%(-96.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | - | 55.49%(+21.2%) |
| Mar 2011 | - | 45.80%(+36.1%) |
| Dec 2010 | 36.24%(-43.6%) | 33.66%(-57.2%) |
| Sep 2010 | - | 78.59%(+56.4%) |
| Jun 2010 | - | 50.26%(-31.9%) |
| Mar 2010 | - | 73.82%(-27.2%) |
| Dec 2009 | 64.25%(-77.1%) | 101.43%(+27.4%) |
| Sep 2009 | - | 79.60%(-15.9%) |
| Jun 2009 | - | 94.69%(-22.4%) |
| Mar 2009 | - | 122.06%(-61.8%) |
| Dec 2008 | 280.99%(-108.8%) | 319.88%(-68.9%) |
| Sep 2008 | - | 1027.71%(+99.6%) |
| Jun 2008 | - | 515.01%(+52.6%) |
| Mar 2008 | - | 337.43%(+77.4%) |
| Dec 2007 | -3192.95%(-2552.2%) | 190.18%(+146.4%) |
| Sep 2007 | - | 77.19%(-5.8%) |
| Jun 2007 | - | 81.96%(-15.5%) |
| Mar 2007 | - | 97.04%(-14.6%) |
| Dec 2006 | 130.21%(+224.6%) | 113.64%(+211.8%) |
| Sep 2006 | - | 36.45%(-4.0%) |
| Jun 2006 | - | 37.95%(-11.2%) |
| Mar 2006 | - | 42.72%(+140.1%) |
| Dec 2005 | 40.12%(-73.9%) | 17.79%(-83.9%) |
| Sep 2005 | - | 110.17%(-25.4%) |
| Jun 2005 | - | 147.69%(-26.5%) |
| Mar 2005 | - | 200.97%(-45.9%) |
| Dec 2004 | 153.70%(+29.1%) | 371.55%(-5.1%) |
| Sep 2004 | - | 391.36%(-0.6%) |
| Jun 2004 | - | 393.90%(+39.2%) |
| Mar 2004 | - | 282.95%(+28.0%) |
| Dec 2003 | 119.06%(-160.7%) | 221.07%(-48.2%) |
| Sep 2003 | - | 426.88%(-167.4%) |
| Jun 2003 | - | -633.13%(+92.2%) |
| Mar 2003 | - | -329.34%(+82.7%) |
| Dec 2002 | -196.17%(+291.9%) | -180.27%(+51.2%) |
| Sep 2002 | - | -119.21%(+45.1%) |
| Jun 2002 | - | -82.13%(+31.8%) |
| Mar 2002 | - | -62.30%(+26.1%) |
| Dec 2001 | -50.05%(-14.2%) | -49.41%(+12.2%) |
| Sep 2001 | - | -44.05%(+15.7%) |
| Jun 2001 | - | -38.06%(+3.3%) |
| Mar 2001 | - | -36.85%(-12.3%) |
| Dec 2000 | -58.35%(-52.4%) | -42.01%(-4.3%) |
| Sep 2000 | - | -43.90%(-19.3%) |
| Jun 2000 | - | -54.42%(-29.3%) |
| Mar 2000 | - | -76.98%(-44.8%) |
| Dec 1999 | -122.52%(-56.8%) | -139.52%(+14.0%) |
| Sep 1999 | - | -122.37%(-47.9%) |
| Jun 1999 | - | -234.97%(+206.3%) |
| Mar 1999 | - | -76.70% |
| Dec 1998 | -283.45%(+48.7%) | - |
| Dec 1997 | -190.64%(-52.2%) | - |
| Dec 1996 | -398.96%(-2072.1%) | - |
| Dec 1995 | 20.23% | - |
FAQ
- What is Abeona Therapeutics annual return on equity?
- What is the all time high annual ROE for Abeona Therapeutics?
- What is Abeona Therapeutics annual ROE year-on-year change?
- What is Abeona Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly ROE year-on-year change?
What is Abeona Therapeutics annual return on equity?
The current annual ROE of ABEO is -260.60%
What is the all time high annual ROE for Abeona Therapeutics?
Abeona Therapeutics all-time high annual return on equity is 280.99%
What is Abeona Therapeutics annual ROE year-on-year change?
Over the past year, ABEO annual return on equity has changed by -145.75% (-126.90%)
What is Abeona Therapeutics quarterly return on equity?
The current quarterly ROE of ABEO is -227.38%
What is the all time high quarterly ROE for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly return on equity is 1027.71%
What is Abeona Therapeutics quarterly ROE year-on-year change?
Over the past year, ABEO quarterly return on equity has changed by 0.00% (0.00%)